An individual partnership theme involving joint research and development of, and a post-launch sales agreement for, a therapeutic app for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) with ASKA Pharmaceutical. Registration of participants in specified clinical research has been completed, and the parties aim to generate milestone payments and post-launch royalties.